Stock A298380 ABL BIO INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases ABL Bio Inc.

Equities

A298380

KR7298380007

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-02 pm EDT 		5-day change 1st Jan Change
25,500 KRW -1.16% Intraday chart for ABL Bio Inc. +2.82% +3.66%
Mar. 25 Biocytogen Pharmaceuticals Co., Ltd. Enters Collaboration with ABL Bio Inc. to Develop New Bispecific Antibody-Drug Conjugates CI
2023 ABL Bio Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific Antibody-Drug Conjugates
AQ
Biocytogen and ABL Bio enter into a collaboration to jointly develop new dual-antibody ADC drugs
AQ
ABL Bio Taps into Synaffix ADC Technology
AQ
ABL Bio Enters Global Collaboration and License Agreement with SANOFI to Advance ABL301 for the Treatment of Parkinson's Disease
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A298380 Stock
  4. News ABL Bio Inc.
  5. Press Releases